Published December 2, 2020 | Version v1
Journal article Open

Keloid in Nigeria: More questions than answers

Authors/Creators

  • 1. ROR icon University of Tennessee at Knoxville
  • 2. University of Ibadan College of Medicine
  • 3. ROR icon University of Ibadan
  • 4. ROR icon Mercer University

Description

Nigeria reported an estimated incidence of 1.5 million in the year 2017 making it one of the highest reasons for dermatology and plastic surgery consults in Nigeria to date. The current available prevalence does not represent the true prevalence of the condition as majority of the keloid affected individuals (Keloid formers) either resort to unorthodox/ traditional therapies while majority do not seek therapy at all. Several hypotheses have been propounded for the pathogenesis of Keloids with no clear definition of the development of the condition. As with its pathogenesis, a definite inheritance pattern has not been established for Keloids. Results from genome wide association studies in different populations have yielded different results of possible candidate loci.
Although very common in Nigeria, its awareness within the population is still very low with several prevailing beliefs about the causes of Keloids within the population. However, majority of these beliefs are wrong. The erroneous beliefs about Keloids among Nigerians most importantly the cosmetic deformity associated with it have contributed negatively to the wellbeing of keloid formers hence making the condition a source of psychological trauma for them.
Here we highlight the current situation of keloids within the Nigerian populace to raise pertinent questions. This will help to ultimately chart a new course for the awareness, acquire a better understanding of the pathogenesis, genetics and socio-cultural factors associated with Keloids among Nigerians.

Files

KeloidsinNigeria.Moarequestionsthananswers.pdf

Files (380.5 kB)

Name Size Download all
md5:e420bc7f1bfc379e39a060a5581dcb2c
380.5 kB Preview Download

Additional details

References

  • Abdus-Salam, A. A., Orekoya, A. A., Jimoh, M. A., & Olabumuyi, A. A. (2016). Radiotherapy Treatment of Keloids in Ibadan. Journal of the West African College of Surgeons, 6(4), 104–116. Adotama, P., Rutherford, A., & Glass, D. A. (2015). Association of keloids with systemic medical conditions: a retrospective analysis. International Journal of Dermatology, 55, 37–55. Alster, T. S., & Tanzi, E. L. (2003). Hypertrophic scars and keloids: Etiology and management. American Journal of Clinical Dermatology, 4(4), 235–243. https://doi.org/10.2165/00128071-200304040-00003 Andrews, J. P., Marttala, J., Macarak, E., Rosenbloom, J., & Uitto, J. (2016). Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment. Matrix Biology, 51, 37–46. https://doi.org/10.1016/j.matbio.2016.01.013 Arima, J., Huang, C., Rosner, B., Akaishi, S., & Ogawa, R. (2015). Hypertension: A systemic key to understanding local keloid severity. Wound Repair and Regeneration, 23(2), 213–221. https://doi.org/10.1111/wrr.12277 Bae-Harboe, Y. S. C., Harboe-Schmidt, J. E., Graber, E., & Gilchrest, B. A. (2014). Collagenase followed by compression for the treatment of earlobe keloids. Dermatologic Surgery, 40(5), 519–524. https://doi.org/10.1111/dsu.12465 Bayat, A., Bock, O., Mrowietz, U., Ollier, W. E. R., & Ferguson, M. W. J. (2004). Genetic susceptibility to keloid disease: Transforming growth factor β receptor gene polymorphisms are not associated with keloid disease. Experimental Dermatology, 13(2), 120–124. https://doi.org/10.1111/j.0906-6705.2004.00165.x Belie, O., Ugburo, A., & Mofikoya, B. (2019). Demographic and clinical characteristics of keloids in an urban center in Sub?Sahara Africa. Nigerian Journal of Clinical Practice, 22(8), 1049–1054. https://doi.org/10.4103/njcp.njcp Bienias, W., Miȩkoś-Zydek, B., & Kaszuba, A. (2011). Current views on the etiopathogenesis of keloids. Postepy Dermatologii i Alergologii, 28(6), 467–475. Bloom D. Heredity of keloids. NYState MedJ. 1956;56:511-519. Bock, O., Schmid-Ott, G., Malewski, P., & Mrowietz, U. (2006). Quality of life of patients with keloid and hypertrophic scarring. Archives of Dermatological Research, 297(10), 433–438. https://doi.org/10.1007/s00403-006-0651-7 Brown, J. J., & Bayat, A. (2009). Genetic susceptibility to raised dermal scarring. British Journal of Dermatology, 161(1), 8–18. https://doi.org/10.1111/j.1365-2133.2009.09258.x Butler, P. D., Longaker, M. T., & Yang, G. P. (2008). Current Progress in Keloid Research and Treatment. Journal of the American College of Surgeons, 206(4), 731–741. https://doi.org/10.1016/j.jamcollsurg.2007.12.001 Chike-Obi, C., Cole, P., & Brissett, A. (2009). Keloids: Pathogenesis, Clinical Features, and Management. Seminars in Plastic Surgery, 23(03), 178–184. https://doi.org/10.1055/s-0029-1224797 D. D. Datubo-Brown and A. Blight. (1990). Inhibition of human fibroblast growth in vitro by a snake oil. British Journal of Plastic Surgery, 43, 183–186. Davidson, S., Aziz, N., Rashid, R. M., & Khachemoune, A. (2009). A primary care perspective on keloids. The Medscape Journal of Medicine, 11(1). https://doi.org/10.1049/ic.2007.1691 De Felice, B., Wilson, R. R., & Nacca, M. (2009). Telomere shortening may be associated with human keloids. BMC Medical Genetics, 10, 110. https://doi.org/10.1186/1471-2350-10-110 Dennie, M. N. (2012). Medical Benefits of the Shea Nut Tree Medical Benefits of the Shea Nut Tree. Biology Student Research. Devika, R., & Arockiamary, S. N. (2011). Aetiology of Keloids – An Overview. Research in Biotechnology, 2(6), 37–43. Dyal, C. M. (1989). Investigation of predictive factors in keloid formation (Vol. 2547). Yale University. Gauglitz, G. G., Korting, H. C., Pavicic, T., Ruzicka, T., & Jeschke, M. G. (2011). Hypertrophic Scarring and Keloids : Pathomechanisms and Current and Emerging Treatment Strategies. 7(12). https://doi.org/10.2119/molmed.2009.00153 Glass, D. A. (2017). Current Understanding of the Genetic Causes of Keloid Formation. Journal of Investigative Dermatology, 18(2), S50–S53. https://doi.org/10.1016/j.jisp.2016.10.024 Hahn, J. M., McFarland, K. L., C, K., & M., D. (2016). Partial epithelial mesenchymal transition in keloid scars : regulation of keloid keratinocyte gene expression by transforming growth factor β1 Article metrics. Burns and Trauma, 4(30). Heitzer, E., Seidl, H., Bambach, I., Schmidbauer, U., Cerroni, L., & Wolf, P. (2012). Infrequent p53 gene mutation but UV gradient-like p53 protein positivity in keloids. Experimental Dermatology, 21(4), 277–280. https://doi.org/10.1111/j.1600-0625.2012.01450.x Henshaw, E., Ibekwe, P., Adeyemi, A., Ameh, S., Ogedegbe, E., Archibong, J., & Olasode, O. (2015). Dermatologic Practice Review of Common Skin Diseases in Nigeria. International Journal of Health Sciences and Research, 5(1), 156–164. Henshaw, E., Ibekwe, P., Adeyemi, A., Ameh, S., Ogedegbe, E., Archibong, J., … State, O. (2018). Dermatologic Practice Review of Common Skin Diseases in Nigeria Eshan. International Journal of Health Sciences and Research, 8(January), 235–248. Janssen de Limpens, A. M. P., & Cormane, R. H. (1982). Keloids and hypertrophic scars-Immunological aspects. Aesthetic Plastic Surgery, 6(3), 149–152. https://doi.org/10.1007/BF01570634 Kelly, A. P. (2009). Update on the Management of Keloids. Seminars in Cutaneous Medicine and Surgery, 28(2), 71–76. https://doi.org/10.1016/j.sder.2009.04.002 Kiprono, S. K., Chaula, B. M., Masenga, J. E., Muchunu, J. W., Mavura, D. R., & Moehrle, M. (2015). Epidemiology of keloids in normally pigmented Africans and African people with albinism: Population-based cross-sectional survey. British Journal of Dermatology, 173(3), 852–854. https://doi.org/10.1111/bjd.13826 Kouotou, E. A., Nansseu, J. R., Omona Guissana, E., Mendouga Menye, C. R., Akpadjan, F., Tounkara, T. M., … Ndjitoyap Ndam, E. C. (2019). Epidemiology and clinical features of keloids in Black Africans: a nested case–control study from Yaoundé, Cameroon. International Journal of Dermatology, 58(10), 1135–1140. https://doi.org/10.1111/ijd.14610 Lee, H. J., & Jang, Y. J. (2018). Recent Understandings of Biology , Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids. International Journal of Molecular Sciences, 19(711). https://doi.org/10.3390/ijms19030711 Lemonas, P., Ahmad, I., D, H. F., Jimenez, G., & Myers, S. (2015). Keloid Scars : The Hidden Burden of Disease. Journal of Pigmentary Disorders, 2(12). https://doi.org/10.4172/2376-0427.1000231 Liberski, S., Marczak, D., & Migdalski, A. (2018). The influence of genetic factors on the pathogenesis of hypertrophic scars and keloids. Journal of Education, Health and Sport., 8(8), 313–321. Lim, C. P., Phan, T. T., Lim, I. J., & Cao, X. (2009). Cytokine profiling and Stat3 phosphorylation in epithelial-mesenchymal interactions between keloid keratinocytes and fibroblasts. Journal of Investigative Dermatology, 129(4), 851–861. https://doi.org/10.1038/jid.2008.337 Louw, L. (2000). Keloids in rural black South Africans. Part 1: General overview and essential fatty acid hypotheses for keloid formation and prevention. Prostaglandins Leukotrienes and Essential Fatty Acids, 63(5), 237–245. https://doi.org/10.1054/plef.2000.0207 Lu, M. Z., Ang, Q. Q., Zhang, X., Zhang, L. F., Yao, X. H., Lv, H., … Lu, W. S. (2018). Genomic risk variants at 3q22.3 are associated with keloids in a Chinese han population. American Journal of Translational Research, 10(2), 554–562. Maderal, A. D., & Berman, B. (2016). Updates on Keloidal Wound Healing. Current Dermatology Reports, 5(4), 252–259. https://doi.org/10.1007/s13671-016-0155-4 Mari, W., Alsabri, S. G., Tabal, N., Younes, S., Sherif, A., & Simman, R. (2015). Novel Insights on Understanding of Keloid Scar: Article Review. Journal of the American College of Clinical Wound Specialists, 7(1–3), 1–7. https://doi.org/10.1016/j.jccw.2016.10.001 Marneros, A. G., Norris, J. E. C., Olsen, B. R., & Reichenberger, E. (2001). Clinical genetics of familial keloids. Archives of Dermatology, 137(11), 1429–1434. https://doi.org/10.1001/archderm.137.11.1429 Mouhari-Toure, A., Saka, B., Kombaté, K., Akakpo, S., Egbohou, P., Tchangaï-Walla, K., & Pitche, P. (2012). Is There an Association between Keloids and Blood Groups? ISRN Dermatology, 2012, 1–4. https://doi.org/10.5402/2012/750908 Mrowietz, U., & Seifert, O. (2009). Keloid Scarring: New Treatments Ahead. Actas Dermo-Sifiliograficas, 100(SUPPL. 2), 75–83. https://doi.org/10.1016/S0001-7310(09)73382-4 Murray, J. C. (1993). Scars and keloids. Dermatologic Clinics, 11(4), 697–708. https://doi.org/10.1136/bmj.328.7452.1329 Nakashima, M., Chung, S., Takahashi, A., Kamatani, N., Kawaguchi, T., Tsunoda, T., … Zembutsu, H. (2010). A genome-wide association study identifies four susceptibility loci for keloid in the japanese population. Nature Genetics, 42(9), 768–772. https://doi.org/10.1038/ng.645 Ogawa, R. (2017). Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. International Journal of Molecular Sciences, 18(3). https://doi.org/10.3390/ijms18030606 Ogawa, R. (2019). Keloids and Hypertrophic Scars Can Now Be Treated Completely by Multimodal Therapy, Including Surgery, Followed by Radiation and Corticosteroid Tape/Plaster. Scars, 1–11. https://doi.org/10.5772/intechopen.84178 Ogawa, R., & Akaishi, S. (2016). Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis – Keloids and hypertrophic scars may be vascular disorders. Medical Hypotheses, 96, 51–60. https://doi.org/10.1016/j.mehy.2016.09.024 Olabanji, J. K. (2011). Clinical Pattern and Management of Keloids in Black Poplulation. East African Medical Journal, 88(4), 125-130–130. Olabanji, J. K., & Oladele, A. . (2011). CLINICAL PATTERN AND MANAGEMENT OF KELOIDS IN BLACK POPULATION. East African MEdical Journal, 88(4), 125–130. Olaitan, P. B. (2009). Keloids: Assessment of effects and psychosocial- impacts on subjects in a black African population. Indian Journal of Dermatology, Venereology and Leprology, 75(4), 368–372. https://doi.org/10.4103/0378-6323.53132 Olasode, O. A. (2010). A Pattern of Breast Hypertrophic and Keloidal Scar : Can a Scar be a Scare in Blacks. Egyptian Dermatology Online Journal, 6(2), 1–12. Omo Dare, P. (1975). Genetic studies on keloid. Journal of the National Medical Association, 67(6), 428–432. Ozioma, E. J., & Ozioma, J. (2019). Herbal Medicines in African Traditional Medicine. In Herbal Medicine (pp. 191–214). https://doi.org/10.5772/intechopen.80348 Penn, J. W., Grobbelaar, A. O., & Rolfe, K. J. (2012). The role of the TGF-β family in wound healing, burns and scarring: a review. International Journal of Burns and Trauma, 2(1), 18–28. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22928164%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3415964 Rathee, M., Kundu, R., & Tamrakar, A. (2014). Custom made pressure appliance for presurgical sustained compression of auricular keloid. Annals of Medical and Health Sciences Research, 4(8), 147. https://doi.org/10.4103/2141-9248.138040 Reichenberger, E. (2012). Why do we know so much about wound healing – and yet so little about Keloids ? Journal of Regenerative Medicine, 1(1), 1–4. Robles, D. T., & Berg, D. (2007). Abnormal wound healing: keloids. Clinics in Dermatology, 25(1), 26–32. https://doi.org/10.1016/j.clindermatol.2006.09.009 Rutherford, A., & Glass, D. A. (2017). A case–control study analyzing the association of keloids with hypertension and obesity. Int J Dermatol, 56(9), 187–189. https://doi.org/10.1111/mec.13536.Application Salami, T., & E Irekpita. (2011). Unusually Located Keloids - The Role of Cultural Practices in its Etiology. Journal of Clinical & Experimental Dermatology, 02(05), 2–4. https://doi.org/10.4172/2155-9554.1000128 Santos-Cortez, R. L. P., Hu, Y., Sun, F., Benahmed-Miniuk, F., Tao, J., Kanaujiya, J. K., … Reichenberger, E. J. (2017). Identification of ASAH1 as a susceptibility gene for familial keloids. European Journal of Human Genetics, 25(10), 1155–1161. https://doi.org/10.1038/ejhg.2017.121 Shaheen, A., Khaddam, J., & Kesh, F. (2016). Risk factors of keloids in Syrians. BMC Dermatology, 16(1), 1–11. https://doi.org/10.1186/s12895-016-0050-5 Shridharani, S. M., Magarakis, M., Manson, P. N., Singh, N. K., Basdag, B., & Rosson, G. D. (2010). The emerging role of antineoplastic agents in the treatment of keloids and hypertrophic scars: A review. Annals of Plastic Surgery, 64(3), 355–361. https://doi.org/10.1097/SAP.0b013e3181afaab0 Slemp, A. E., & Kirschner, R. E. (2006). Keloids and scars: A review of keloids and scars, their pathogenesis, risk factors, and management. Current Opinion in Pediatrics, 18(4), 396–402. https://doi.org/10.1097/01.mop.0000236389.41462.ef Stahl, S., Barnea, Y., Weiss, J., Amir, A., Zaretski, A., Leshem, D., … Gur, E. (2010). Treatment of earlobe keloids by extralesional excision combined with preoperative and postoperative "sandwich" radiotherapy. Plastic and Reconstructive Surgery, 125(1), 135–141. https://doi.org/10.1097/PRS.0b013e3181c2a46e Trace, A. P., Enos, C. W., Mantel, A., & Harvey, V. M. (2016). Keloids and Hypertrophic Scars: A Spectrum of Clinical Challenges. American Journal of Clinical Dermatology, 17(3), 201–223. https://doi.org/10.1007/s40257-016-0175-7 Tziotzios, C., Profyris, C., & Sterling, J. (2012). Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics: Part II. Strategies to reduce scar formation after dermatologic procedures. Journal of the American Academy of Dermatology, 66(1), 13–24. 11 https://doi.org/10.1016/j.jaad.2011.08.035 Velez, D. R., Krystal, E., Williams, S. M., Edwards, T. L., & Russell, S. B. (2014). Admixture mapping identifies a locus at 15q21 . 2 – 22 . 3 associated with keloid formation in African Americans. 1513–1523. https://doi.org/10.1007/s00439-014-1490-9 Wolfram, D., Tzankov, A., Pülzl, P., & Piza-Katzer, H. (2009). Hypertrophic scars and keloids - A review of their pathophysiology, risk factors, and therapeutic management. Dermatologic Surgery, 35(2), 171–181. https://doi.org/10.1111/j.1524-4725.2008.34406.x Wu, Y., Wang, B., Li, Y. H., Xu, X. G., Luo, Y. J., Chen, J. Z. S., … Chen, H. D. (2012). Meta-analysis demonstrates association between Arg72Pro polymorphism in the P53 gene and susceptibility to keloids in the Chinese population. Genetics and Molecular Research, 11(2), 1701–1711. https://doi.org/10.4238/2012.June.29.2